ACC 2023: Late-Breaking Science Video Collection

Published: 06 March 2023

Views:
5693
Likes:
7

Views:
5693
Likes:
7
Share:

Now Playing
Part 4 | Session 1 of 4
Interventional Late-breaking Highlights with Dr Mirvat Alasnag & Dr Khaled Al-Shaibi
Mirvat Alasnag, Khaled Al-Shaibi

Up Next
5m 34s

Part 4 | Session 2 Lipid Management & the CLEAR Trial with Dr Erin Michos
Erin D Michos
17m 7s

Part 4 | Session 3 Obesity Management Strategies in 2023 with Dr Harold Bays
Harold Bays
15m 9s

Part 4 | Session 4 ACC.23 President Interview with Dr B Hadley Wilson
B Hadley Wilson

1m 17s

Part 5 | Session 1 Dr Akowuah: Cardiovascular Research & Message for Early-Career Researchers
Enoch Akowuah
1m 22s

Part 5 | Session 2 Dr Kini: Asking Questions & Her Motivation to Do Research on Plaque
Annapoorna Kini
5m 29s

Part 5 | Session 3 Drs Day, Lambert & Ackerman: Passion For Cardiovascular Research & Advice for Researchers
Sharlene Day, Rachel Lampert, Michael Ackerman
1m 21s

Part 5 | Session 4 Dr Verma: Passion for Electrophysiology & His Advice For Young Researchers
Atul Verma
3m 33s

Part 5 | Session 5 Dr Wilson on Why Did He Choose Cardiology & His Advice for Early-career Faculty
B Hadley Wilson
31s

Part 5 | Session 6 Dr Hahn: Innovative Areas of Cardiovascular Science in 2023
Joo-Yong Hahn
1m 33s

Part 5 | Session 7 Dr Forrest: Structural Heart Innovations and Advice to Young Researchers
John Forrest

16m 12s

Part 1 | Session 1 The CLEAR-Outcomes Trial with Dr Harriette Van Spall & Dr Steven Nissen Harriette Van Spall, Steven E Nissen

16m 24s

Part 1 | Session 2 The REVIVED-BCIS2 Viability Study with Dr Harriette Van Spall, Dr Divaka Perera & Dr Peter O'Kane Harriette Van Spall, Divaka Perera, Peter O’Kane

14m 3s

Part 1 | Session 3 The BETTER-CARE HF Trial with Dr Harriette Van Spall & Dr Amrita Mukhopadhyay Amrita Mukhopadhyay, Harriette Van Spall

17m 32s

Part 1 | Session 4 The COORDINATE-Diabetes Trial with Dr Harriette Van Spall, Dr Neha J Pagidipati & Dr Christopher B Granger Christopher B Granger, Harriette Van Spall, Neha Pagidipati

12m 7s

Part 1 | Session 5 The BIOVASC Trial with Dr Harriette Van Spall & Prof Roberto Diletti Roberto Diletti, Harriette Van Spall

5m 59s

Part 2 | Session 1 Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial Marielle Scherrer-Crosbie

5m 38s

Part 2 | Session 2 RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI Joo-Yong Hahn

8m 1s

Part 2 | Session 3 Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study Annapoorna Kini

5m 41s

Part 2 | Session 4 Mini-Thoracotomy Vs Sternoctomy for Degenerative Valve Disease: The UK Mini-Mitral Study Enoch Akowuah

3m 46s

Part 2 | Session 5 TAVR in Low-Risk Aortic Stenosis Patients: 3-Year Results From the Evolut Low Risk Trial John Forrest

5m 53s

Part 2 | Session 6 Pulsed Field Ablation in Persistent Atrial Fibrillation Patients: The PULSED AF Trial Atul Verma

3m 44s

Part 2 | Session 7 MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients Christie Ballantyne

5m 21s

Part 2 | Session 8 Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF Barry Borlaug

3m 7s

Part 2 | Session 9 BMAD Trial: μCor in Ambulatory Decompensated Heart Failure John Boehmer

5m 44s

Part 2 | Session 10 The STELLAR Phase II Trial: Sotatercept in Patients With Pulmonary Arterial Hypertension Marius Hoeper

8m 2s

Part 2 | Session 11 Inflammatory Risk from Statin-Treated Patients: Findings from PROMINENT, REDUCE-IT and STRENGTH Paul M Ridker

33m 36s

Part 3 | Session 1 ACC.23 Late-breaking Science Wrap Up Nicolas M Van Mieghem, Joost Daemen

22m 4s

Part 3 | Session 2 What's Hot at ACC.23? Late-breaking Science Preview Nicolas M Van Mieghem, Joost Daemen

Average (ratings)

No ratings

Your rating

Overview

Our regular review series View from the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provides a critical analysis of the late-breaking and featured science results and spotlights impactful data.

For a deeper look into the key clinical trial data revealed at ACC 23, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviews the principal investigators in her regular Late-Breaker Discussion Series.

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.

More from this programme

Part 1

Late-Breaker Discussion Series

Host, Dr Harriette Van Spall is joined by principle investigators for discussion on selected late-breaking trials.

5 sessions
The CLEAR-Outcomes Trial with Dr Harriette Van Spall & Dr Steven Nissen	Watch now
The REVIVED-BCIS2 Viability Study with Dr Harriette Van Spall, Dr Divaka Perera & Dr Peter O'Kane	Watch now
The BETTER-CARE HF Trial with Dr Harriette Van Spall & Dr Amrita Mukhopadhyay	Watch now
The COORDINATE-Diabetes Trial with Dr Harriette Van Spall, Dr Neha J Pagidipati & Dr Christopher B Granger	Watch now
The BIOVASC Trial with Dr Harriette Van Spall & Prof Roberto Diletti	Watch now

Part 2

Expert Interviews

11 sessions
Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial	Watch now
RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI	Watch now
Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study	Watch now
Mini-Thoracotomy Vs Sternoctomy for Degenerative Valve Disease: The UK Mini-Mitral Study	Watch now
TAVR in Low-Risk Aortic Stenosis Patients: 3-Year Results From the Evolut Low Risk Trial	Watch now
Pulsed Field Ablation in Persistent Atrial Fibrillation Patients: The PULSED AF Trial	Watch now
MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients	Watch now
Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF	Watch now
BMAD Trial: μCor in Ambulatory Decompensated Heart Failure	Watch now
The STELLAR Phase II Trial: Sotatercept in Patients With Pulmonary Arterial Hypertension	Watch now
Inflammatory Risk from Statin-Treated Patients: Findings from PROMINENT, REDUCE-IT and STRENGTH	Watch now

Part 3

View from the Thoraxcenter

In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at ACC 2023.

2 sessions
ACC.23 Late-breaking Science Wrap Up	Watch now
What's Hot at ACC.23? Late-breaking Science Preview	Watch now

Part 4

Highlights Reviews

4 sessions
Interventional Late-breaking Highlights with Dr Mirvat Alasnag & Dr Khaled Al-Shaibi	Watch now
Lipid Management & the CLEAR Trial with Dr Erin Michos	Watch now
Obesity Management Strategies in 2023 with Dr Harold Bays	Watch now
ACC.23 President Interview with Dr B Hadley Wilson	Watch now

Part 5

Behind the Heart

Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.

7 sessions
Dr Akowuah: Cardiovascular Research & Message for Early-Career Researchers	Watch now
Dr Kini: Asking Questions & Her Motivation to Do Research on Plaque	Watch now
Drs Day, Lambert & Ackerman: Passion For Cardiovascular Research & Advice for Researchers	Watch now
Dr Verma: Passion for Electrophysiology & His Advice For Young Researchers	Watch now
Dr Wilson on Why Did He Choose Cardiology & His Advice for Early-career Faculty	Watch now
Dr Hahn: Innovative Areas of Cardiovascular Science in 2023	Watch now
Dr Forrest: Structural Heart Innovations and Advice to Young Researchers	Watch now

About the episode

Dr Khaled Al-Shaibi and Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SB) joined us to discuss the top 5 late-breaking interventional cardiology highlights of ACC.

In this discussion, interventional experts delve into the latest research, findings and considerations for practice from trials, including:

0:29: The RENOVATE-COMPLEX-PCI Trial
6:22: The BIOVASC Trial
7:11: TRILUMINATE Trial
10:30: The COAPT Trial
13:17: The Evolut Low Risk Trial

Faculty Biographies

Mirvat Alasnag

Director of Catheterization Laboratory

Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).

Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.

Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date,…